Chandra P Prasad
Overview
Explore the profile of Chandra P Prasad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhat A, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad C, et al.
Cancer Commun (Lond)
. 2022 Jul;
42(8):689-715.
PMID: 35791509
Colorectal cancer (CRC) is a predominant life-threatening cancer, with liver and peritoneal metastases as the primary causes of death. Intestinal inflammation, a known CRC risk factor, nurtures a local inflammatory...
2.
Pathak N, Sharma A, Elavarasi A, Sankar J, Deo S, Sharma D, et al.
Breast
. 2022 Apr;
64:7-18.
PMID: 35462344
Importance: Carboplatin increases the pathological complete remission (pCR) rate in triple negative breast cancer (TNBC) when added to neoadjuvant chemotherapy, however, evidence on its effect on survival outcomes is controversial....
3.
Canesin G, Evans-Axelsson S, Hellsten R, Krzyzanowska A, Prasad C, Bjartell A, et al.
PLoS One
. 2017 Sep;
12(9):e0184418.
PMID: 28886116
Prostate cancer patients with high WNT5A expression in their tumors have been shown to have more favorable prognosis than those with low WNT5A expression. This suggests that reconstitution of Wnt5a...
4.
Linnskog R, Jonsson G, Axelsson L, Prasad C, Andersson T
Mol Oncol
. 2014 Jun;
8(8):1365-78.
PMID: 24954857
Extensive research has demonstrated a tumor-promoting role of increased WNT5A expression in malignant melanoma. However, very little light has been shed upon how WNT5A expression is up-regulated in melanoma. A...
5.
Prasad C, Rath G, Mathur S, Bhatnagar D, Ralhan R
Chem Biol Interact
. 2009 Dec;
183(3):455-61.
PMID: 19944674
In breast cancer, maspin, a serine protease inhibitor, can suppress tumor growth and metastasis in vivo and tumor cell motility and invasion in vitro. The clinical significance of maspin expression...
6.
Prasad C, Rath G, Mathur S, Bhatnagar D, Parshad R, Ralhan R
BMC Cancer
. 2009 Sep;
9:325.
PMID: 19751508
Background: Cancer progression is linked to a partially dedifferentiated epithelial cell phenotype. The signaling pathways Wnt, Hedgehog, TGF-beta and Notch have been implicated in experimental and developmental epithelial mesenchymal transition...
7.
Prasad C, Rath G, Mathur S, Bhatnagar D, Ralhan R
Chem Biol Interact
. 2009 Jul;
181(2):263-71.
PMID: 19573523
Abnormal activation of the Wnt/beta-catenin signaling pathway and subsequent upregulation of beta-catenin driven downstream targets-c-Myc and cyclin D1 is associated with development of breast cancer. The objective of our study...
8.
Prasad C, Mirza S, Sharma G, Prashad R, Dattagupta S, Rath G, et al.
Life Sci
. 2008 Jul;
83(9-10):318-25.
PMID: 18662704
Activation of canonical Wnt/beta-catenin pathway in Invasive Ductal Carcinoma of Breast (IDCs) was recently reported from our laboratory. Herein, we analyzed promoter methylation status of CDH1 and Adenomatous polyposis coli...
9.
Prasad C, Gupta S, Rath G, Ralhan R
Oncology
. 2008 Mar;
73(1-2):112-7.
PMID: 18337623
Objective: The Wnt/beta-catenin signaling cascade is an important signal transduction pathway in human cancers. Overexpression of beta-catenin and its downstream effector, cyclin D1, is implicated in malignant transformation and acquisition...
10.
Mirza S, Sharma G, Prasad C, Parshad R, Srivastava A, Gupta S, et al.
Life Sci
. 2007 Jun;
81(4):280-7.
PMID: 17599361
Breast cancer is fast emerging as the leading cancer amongst females, especially in younger age group in India; a large proportion of these tumors are often aggressive and ER and/or...